Joel C. Marrs

ORCID: 0000-0003-0392-3866
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Practices and Patient Outcomes
  • Lipoproteins and Cardiovascular Health
  • Blood Pressure and Hypertension Studies
  • Medical and Biological Sciences
  • Medication Adherence and Compliance
  • Diabetes Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Pharmacology and Obesity Treatment
  • Hormonal Regulation and Hypertension
  • Mobile Health and mHealth Applications
  • Heart Failure Treatment and Management
  • Digital Mental Health Interventions
  • Innovations in Medical Education
  • Metabolism, Diabetes, and Cancer
  • Pancreatic function and diabetes
  • Atrial Fibrillation Management and Outcomes
  • Patient Safety and Medication Errors
  • Acute Ischemic Stroke Management
  • Pharmaceutical Economics and Policy
  • Sodium Intake and Health
  • Antiplatelet Therapy and Cardiovascular Diseases
  • COVID-19 Clinical Research Studies
  • Diet and metabolism studies
  • HIV-related health complications and treatments

University of Tennessee at Knoxville
2025

University of Colorado Denver
2013-2024

University of Tennessee Health Science Center
2023-2024

American College of Clinical Pharmacy
2009-2024

University of Colorado Anschutz Medical Campus
2011-2024

Olympic Park Sports Medicine Centre
2023

Billings Clinic
2022

American Association of Colleges of Pharmacy
2022

Public Health England
2021

University of Montana
2012-2020

Abstract Medication adherence is the extent to which a patient follows prescribed directions when taking medication. Research examining interventions relating medication becoming increasingly important for payers, providers, and researchers inform clinical practice utilization policies medications. Multiple methods exist measuring adherence, choice of methodology should be based on research design, data availability, study aims. In this review, common in retrospective studies using...

10.1002/jac5.1771 article EN JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2023-02-25

Data describing the use of recommended antihypertensive agents in resistant hypertension population are limited. Treatment recommendations for include maximizing diuretic therapy by using chlorthalidone and/or adding an aldosterone antagonist. Additional combining from different drug classes. This retrospective cohort study describes patients with defined as concurrent ≥4 agents. Claims data Medstat MarketScan Commercial and Encounter database were used to identify based on International...

10.1161/hypertensionaha.111.180497 article EN Hypertension 2011-11-01

Abstract Background Nearly half of patients do not take their cardiovascular medications as prescribed, resulting in increased morbidity, mortality, and healthcare costs. Mobile digital technologies for health promotion disease self-management offer an opportunity to adapt behavioral “nudges” using ubiquitous mobile phone technology facilitate medication adherence. The Nudge pragmatic clinical trial uses population-level pharmacy data deliver nudges via text messaging artificial intelligent...

10.1186/s13063-021-05453-9 article EN cc-by Trials 2021-08-11

The objectives of this retrospective study were to examine the feasibility and characteristics that define successful implementation a Clinical Pharmacy Specialist (CPS) telephonic hospital discharge follow-up quality improvement initiative, as well impact initiative. Adult patients who discharged from safety-net between July 1, 2010 June 30, 2011 part patient-centered medical home included in CPSs attempted contact 470 patients; those, 207 received intervention 263 did not. Patients...

10.1089/pop.2012.0070 article EN Population Health Management 2013-03-28

10.1016/j.amjmed.2016.08.010 article EN The American Journal of Medicine 2016-09-09

Board certification is a means of demonstrating expertise above the minimum licensing standards. For many health care professionals, this credential necessity. As pharmacists become involved in more advanced patient services, board becomes an essential component to ensuring quality care. The prevalence United States pharmacy practice faculty members who are certified, however, unknown. In addition, our knowledge, factors that serve motivate or discourage from obtaining have not been...

10.1002/phar.1171 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2013-01-01

Background: The American College of Cardiology/American Heart Association (ACC/AHA) Guideline on the Treatment Blood Cholesterol recommends high-intensity statin therapy for most patients with established atherosclerotic cardiovascular disease (ASCVD) versus previously recommended low-density lipoprotein cholesterol targets. impact ACC/AHA guidelines prescribing patterns in primary care is uncertain. Objective: To describe habits ASCVD before and after were published. Methods: This...

10.1177/1060028015608199 article EN Annals of Pharmacotherapy 2015-09-28

Consistent with the American College of Clinical Pharmacy's vision that future clinical pharmacy practitioners who provide direct patient care should be board-certified specialists, a new framework for pharmacist specialty board certification is proposed. This White Paper describes current and projected needs profession regarding certification, provides rationale framework, discusses potential ramifications changes in board-certification process.

10.1592/phco.29.4.489 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2009-03-26

Objective: To review the pharmacology, pharmacokinetics, pharmacodynamics, efficacy data, and adverse effects of indiplon in treatment transient chronic insomnia adult geriatric patients. Data Sources: A literature search was conducted using MEDLINE (1966–May 2006), International Pharmaceutical Abstracts (1970–May 2008), Cochrane database (2007) (or key words or NBI-34060. References cited articles were reviewed for additional Information. Abstract data included only absence significant...

10.1345/aph.1k683 article EN Annals of Pharmacotherapy 2008-05-27
Coming Soon ...